VISTIN PHARMA ASA: årsregnskap 2019 vs 2018
Grew 100% on revenue, cash halved-plus
approved 2020-04-22; registry 2020-07-16; journal 2020 586240
Summary
What changed
Comparing Årsregnskap 2019 with 2018 for VISTIN PHARMA ASA. Revenue -5.50m NOK → 0 NOK (+100.0%). Equity 338.5k NOK → 338.8k NOK.
On the constructive side: revenue rose. Pressures included: cash fell; current ratio dropped below 1×.
Also worth watching: sharp cash drawdown; paid-in equity reduced; payroll increased. All figures are taken from the published annual accounts for VISTIN PHARMA ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from -5.50m NOK to 0 NOK (+100.0% YoY). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 141.36m NOK → 180.2k NOK (-99.9% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 25.38× → 0.01× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (141.36m NOK → 180.2k NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Paid-in equity reduced
Paid-in equity fell 320.52m NOK → 338.8k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Payroll increased
Salary cost 1.61m NOK → 1.64m NOK. Calculated
-
·
Book investments changed
Investment / intangible book value 194.63m NOK → 127.93m NOK. Reported fact